Immuron IMRN
NASDAQ IMRN
$1.12 -0.06 (-5.08%)
As of: Aug 21, 2026 · 3:58 PM EDT

Immuron (IMRN) Interest & Investment Income (2017 - 2024)

Immuron (IMRN) posted quarterly Interest & Investment Income of $35.3 billion for Q4 2024, up 23001335.32% year-over-year from N/an in Q1 2024, and up 23001335.32% quarter-over-quarter from $153508.0 in Q4 2023.

Immuron (IMRN) Interest & Investment Income (2017 - 2024) Analysis & Trends

Immuron's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $35.3 billion for Q4 2024.

  • In Q4 2024, Interest & Investment Income rose 23001335.32% year-over-year to $35.3 billion; the TTM figure through Dec 2024 stood at $35.3 billion (up 16998463.83% YoY), while the FY2025 annual figure was $88058.7, down 59.03% from the prior year.
  • Interest & Investment Income for Q4 2024 stood at $35.3 billion, up from $153508.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $35.3 billion in Q4 2024, with the low at $63.29 in Q4 2020.
  • The 5-year median for Interest & Investment Income is $54072.0 (2022), against an average of $7.1 billion.
  • The sharpest annual moves came in 2021 and 2024: Interest & Investment Income grew 19.66% in 2021, then jumped 23001335.32% in 2024.
  • Immuron's Interest & Investment Income stood at $63.29 in 2020, then rose by 19.66% to $75.73 in 2021, then soared by 71296.7% to $54072.0 in 2022, then surged by 183.9% to $153508.0 in 2023, then surged by 23001335.32% to $35.3 billion in 2024.
  • Business Quant data shows IMRN's Interest & Investment Income at $35.3 billion in Q4 2024, $153508.0 in Q4 2023, and $54072.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 67.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 27.90 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 28.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 115.94 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 10.98 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 5.13 Mn
10 Immuron 6.75 Mn 6.73 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 35.31 Bn
Dec 31, 2023 153,508.00
Dec 31, 2022 54,072.00
Dec 31, 2021 75.73
Dec 31, 2020 63.29
Dec 31, 2019 2.59
Dec 31, 2018 39.00
Dec 31, 2017 33.51